3/1
03:31 am
mdxg
MiMedx Group (MDXG) Delivers Record Full Year Revenue [Yahoo! Finance]
Low
Report
MiMedx Group (MDXG) Delivers Record Full Year Revenue [Yahoo! Finance]
2/25
06:31 pm
mdxg
MiMedx (MDXG) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
MiMedx (MDXG) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/25
04:50 pm
mdxg
MiMedx: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
MiMedx: Q4 Earnings Snapshot [Yahoo! Finance]
2/25
04:01 pm
mdxg
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results
Medium
Report
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results
2/23
08:04 am
mdxg
MiMedx Group (NASDAQ:MDXG) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $10.00 price target on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $10.00 price target on the stock.
2/23
06:04 am
mdxg
MiMedx Group (NASDAQ:MDXG) is now covered by analysts at Citigroup Inc.. They set a "market outperform" rating on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) is now covered by analysts at Citigroup Inc.. They set a "market outperform" rating on the stock.
2/23
06:03 am
mdxg
MiMedx Group (NASDAQ:MDXG) was given a new $10.00 price target on by analysts at UBS Group AG.
Low
Report
MiMedx Group (NASDAQ:MDXG) was given a new $10.00 price target on by analysts at UBS Group AG.
2/23
12:36 am
mdxg
How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions [Yahoo! Finance]
Medium
Report
How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions [Yahoo! Finance]
2/17
10:33 am
mdxg
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Cantor Fitzgerald from $12.00 to $8.00. They now have an "overweight" rating on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Cantor Fitzgerald from $12.00 to $8.00. They now have an "overweight" rating on the stock.
2/17
08:21 am
mdxg
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 [Yahoo! Finance]
Low
Report
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 [Yahoo! Finance]
2/17
08:00 am
mdxg
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
Low
Report
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
2/4
11:11 am
mdxg
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products [Yahoo! Finance]
Low
Report
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products [Yahoo! Finance]
2/4
10:27 am
mdxg
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
Low
Report
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
2/2
03:38 pm
mdxg
Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance [Yahoo! Finance]
Low
Report
Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance [Yahoo! Finance]
2/2
08:00 am
mdxg
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
Low
Report
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
1/20
03:10 pm
mdxg
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Lake Street Capital from $12.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Lake Street Capital from $12.00 to $10.00. They now have a "buy" rating on the stock.
1/16
08:51 am
mdxg
Recent 8.9% pullback isn't enough to hurt long-term MiMedx Group (NASDAQ:MDXG) shareholders, they're still up 70% over 3 years [Yahoo! Finance]
Low
Report
Recent 8.9% pullback isn't enough to hurt long-term MiMedx Group (NASDAQ:MDXG) shareholders, they're still up 70% over 3 years [Yahoo! Finance]
12/22
10:36 am
mdxg
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel [Yahoo! Finance]
Low
Report
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel [Yahoo! Finance]
12/22
09:43 am
mdxg
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
Low
Report
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
12/20
08:22 am
mdxg
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest [Yahoo! Finance]
Low
Report
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest [Yahoo! Finance]
12/19
10:09 am
mdxg
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro [Yahoo! Finance]
Low
Report
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro [Yahoo! Finance]
12/19
09:00 am
mdxg
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
Low
Report
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
12/17
08:24 am
mdxg
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Mizuho from $12.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Mizuho from $12.00 to $10.00. They now have an "outperform" rating on the stock.
12/17
03:51 am
mdxg
?????????? - ??????????????????2026-2035? [CNET News]
Low
Report
?????????? - ??????????????????2026-2035? [CNET News]